Optimizing Ovarian Cancer Treatment and Prevention Through Parallel Germline and Somatic Genetic Testing
- PMID: 38862010
- DOI: 10.6004/jnccn.2024.7042
Optimizing Ovarian Cancer Treatment and Prevention Through Parallel Germline and Somatic Genetic Testing
Comment on
-
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer.J Natl Compr Canc Netw. 2024 Apr 18;22(2 D):e237331. doi: 10.6004/jnccn.2023.7331. J Natl Compr Canc Netw. 2024. PMID: 38866043
Similar articles
-
Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.Gynecol Oncol. 2016 Jan;140(1):90-4. doi: 10.1016/j.ygyno.2015.10.010. Epub 2015 Oct 22. Gynecol Oncol. 2016. PMID: 26475959
-
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer.J Natl Compr Canc Netw. 2024 Apr 18;22(2 D):e237331. doi: 10.6004/jnccn.2023.7331. J Natl Compr Canc Netw. 2024. PMID: 38866043
-
Germline and Somatic Testing in Ovarian Cancer: Shifting Sands of Recommendations.Gynecol Oncol. 2020 Mar;156(3):515-516. doi: 10.1016/j.ygyno.2020.02.009. Epub 2020 Feb 24. Gynecol Oncol. 2020. PMID: 32127132 No abstract available.
-
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.Breast Cancer Res Treat. 2016 Dec;160(3):393-410. doi: 10.1007/s10549-016-4003-9. Epub 2016 Oct 12. Breast Cancer Res Treat. 2016. PMID: 27734215 Review.
-
Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.Future Oncol. 2016 Sep;12(18):2071-5. doi: 10.2217/fon-2016-0189. Epub 2016 May 31. Future Oncol. 2016. PMID: 27241581 Review. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical